Liraglutide
- EASTCHEM
- China
- 15~20 days
- 204656-20-2
Liraglutide is a high-purity, research-grade GLP-1 analog peptide that safely and effectively regulates blood sugar, serving as a second-line treatment for diabetes and an anti-obesity agent. It prolongs plasma half-life, reduces cardiovascular risk, and supports chronic disease management.
Product introduction
Liraglutide (CAS: 204656-20-2) is an antidiabetic drug used to treat type 2 diabetes and is also an important drug in the treatment of chronic obesity. As a GLP-1 (glucagon-like peptide-1) analog, liraglutide helps patients manage blood sugar and weight by stimulating insulin secretion, lowering blood glucose levels, and suppressing appetite. It is often used as a second-line diabetes treatment when metformin, the first-line drug, is ineffective.
Product Features
High-purity, research-grade Liraglutide, HPLC ≥ 98%
Similar to GLP-1 peptide structure, with significant glycemic regulation effects
Prolongs plasma half-life, reducing dosing frequency
Suitable for drug development, injection experiments, and metabolic disease research
Meets research standards, easy to store and operate experimentally
Product application
Type 2 Diabetes Treatment: Improves pancreatic function and controls blood sugar levels.
Chronic Obesity Management: Used for long-term weight loss, helping to reduce BMI and body fat.
Research Applications: Suitable for GLP-1-related drug development, metabolic disease research, and drug development experiments.
Contact Us
If you require Semaglutide supply or more technical information, please contact [East Chemical]. We offer high-purity, customizable packaging and fast shipping services to support research and drug development needs.